Advertisement

PRP in Lateral Elbow Pain

  • Jorge Guadilla
  • Emilio Lopez-Vidriero
  • Rosa Lopez-Vidriero
  • Sabino Padilla
  • Diego Delgado
  • Rafael Arriaza
  • Mikel Sanchez
Chapter

Abstract

The lateral elbow pain is a common condition that usually affects young active patients and used to be related either to labor or sport repetitive movements involving the forearm extensors. The differential diagnosis is mandatory and should distinguish among lateral tendinopathy, intra-articular problems, and even neuropathies that could present with lateral elbow pain. In those cases in which rest and avoidance or modification of the causative activities do not lead to a remission in symptoms, different nonoperative treatment could be useful. In case of absence of response to conservative therapies, surgery could be needed. In the last decade the interest in regenerative therapies has increased extraordinarily. Thus, different studies on the utility and efficiency of platelet-rich plasma (preparation rich in patient’s own blood growth factors) in the treatment of lateral elbow tendinopathy have been performed with confusing results.

Probably the differences among the different systems of platelet-rich plasma and the variety of application protocols do not help in clarifying the real efficacy of this therapy.

Keywords

Extracorporeal Shock Wave Therapy Osteochondritis Dissecans Lateral Epicondylitis Tendon Cell Posterior Interosseous Nerve 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Runge F. Zur Genese und Behandlung des schreibe Kranfes. Bed Klin Worchenschr. 1873;10:245–8 (in German).Google Scholar
  2. 2.
    Major HP. Lawn-tennis elbow. BMJ. 1883;2:557. letter.Google Scholar
  3. 3.
    Luk J, Tsang R, Leung HB. Lateral epicondylalgia: midlife crisis of a tendón. Hong Kong Med J. 2014;20:145–51.PubMedGoogle Scholar
  4. 4.
    Nirschl RP. Tennis elbow. Orthop Clin North Am. 1973;4:787–800.PubMedGoogle Scholar
  5. 5.
    Nirschl RP. Elbow tendinosis/tennis elbow. Clin Sports Med. 1992;11:851–70.PubMedGoogle Scholar
  6. 6.
    Bishai SK, Plancher KD. The basic science of lateral epicondylosis: update for the future. Technol Orthop. 2006;21:250–5.CrossRefGoogle Scholar
  7. 7.
    Kannus P, Józsa L. Histopathological changes preceding spontaneous rupture of a tendon: a controlled study of 891 patients. J Bone Joint Surg Am. 1991;73-A:1507–25.Google Scholar
  8. 8.
    Kraushaar BS, Nirschl RP. Tendinosis of the elbow (tennis elbow). Clinical features and findings of histological, immunohistochemical, and electron microscopy studies. J Bone Joint Surg Am. 1999;81:259–78.CrossRefPubMedGoogle Scholar
  9. 9.
    Baker CL, Nirschl RP. Lateral tendon injury: open and arthroscopic treatment. In: Altchek DW, Andrews JR, editors. The Athlete’s elbow. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 91–103.Google Scholar
  10. 10.
    Schulze-Tanzil G, Al-Sadi O, Wiegand E, Ertel W, Busch C, Kohl B, Pufe T. The role of pro- inflammatory and immunoregulatory cytokines in tendon healing and rupture: new insights. Scand J Med Sci Sports. 2011;21(3):337–51.CrossRefPubMedGoogle Scholar
  11. 11.
    Rees JD, et al. Tendons – time to revisit inflammation. Br J Sports Med. 2014;48:1553–7.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Cyriax JH. The pathology and treatment of tennis elbow. J Bone Joint Surg. 1936;18:921–40.Google Scholar
  13. 13.
    Walker-Bone K, Palmer KT, Reading I, Coggon D, Cooper C. Prevalence and impact of musculoskeletal disorders of the upper limb in the general population. Arthritis Rheum. 2004;51:642–51.CrossRefPubMedGoogle Scholar
  14. 14.
    Sanders TL et al. The epidemiology and health care burden of tennis elbow. A population- based study. Am J Sports Med. 2015; pii: 0363546514568087. [Epub ahead of print].Google Scholar
  15. 15.
    Shiri R, Viikari-Juntara E. Lateral and medial epicondylitis: role of occupational factors. Best Pract Res Clin Rheumatol. 2011;25:43–57.CrossRefPubMedGoogle Scholar
  16. 16.
    Shiri R, Viikari-Juntura E, Varonen H, et al. Prevalence and determinants of lateral and medial epicondylitis: a population study. Am J Epidemiol. 2006;164:1065–74.CrossRefPubMedGoogle Scholar
  17. 17.
    Shiri R, Varonen H, Heliövaara M, Viikari-Juntura E. Hand dominance in upper extremity musculoskeletal disorders. J Rheumatol. 2007;34(5):1076–82.PubMedGoogle Scholar
  18. 18.
    Hamilton PG. The prevalence of humeral epicondylitis: a survey in general practice. J R Coll Gen Pract. 1986;36(291):464–5.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Boyer MI, Hastings II H. Lateral tennis elbow: “Is there any science out there?”. J Shoulder Elbow Surg. 1999;8:481–91.CrossRefPubMedGoogle Scholar
  20. 20.
    Priest JD, Braden V, Gerberich JG. The elbow and tennis. Part 1. Phys Sports Med. 1980;8:80.Google Scholar
  21. 21.
    Fichez O. Epicondylite: histoire naturelle et etude critique des differents traitements. J Traumatol Sport. 1998;15(3):163–72.Google Scholar
  22. 22.
    De Smedt T, de Jong A, Leemput WV, et al. Lateral epicondylitis in tennis: update on aetiology, biomechanics, and treatment. Br J Sports Med. 2007;41:816–9.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Eygendaal D, Rahussen FTG, Diercks RL. Biomechanics of the elbow joint in tennis players and relation to pathology. Br J Sports Med. 2007;41:820–3.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Tosti R, Jennings J, Sewards JM. Lateral epicondylitis of the elbow. Am J Med. 2013;126(357):357. e1-357.e6.PubMedGoogle Scholar
  25. 25.
    Hume PA, Reid D, Edwards T. Epicondylar injury in sport. Epidemiology, type, mechanisms, assessment, management and prevention. Sports Med. 2006;36(2):151–70.CrossRefPubMedGoogle Scholar
  26. 26.
    Sánchez M, Anitua E. A new biological approach to orthopedic surgery and sports medicine. 1st ed. Vitoria: Team Work Media; 2013. Chapter 144–58.Google Scholar
  27. 27.
    Behzad H, Sharma A, Mousavizadeh R, et al. Mast cells exert pro-inflammatory effects of relevance to the pathophysiology of tendinopathy. Arthritis Res Ther. 2013;15(6):R184.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Sharma P, Maffulli N. Tendon injury and tendinopathy: healing and repair. J Bone Joint Surg Am. 2005;87:187–202.CrossRefPubMedGoogle Scholar
  29. 29.
    Alfredson H, Bjur D, Thorsen K, Lorentzon R, Sandstrom P. High intratendinous lactate levels in painful chronic Achilles tendinosis. An investigation using microdialysis technique. J Orthop Res. 2002;20:934–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Alfredson H, Ohberg L. Sclerosing injections to areas of neo-vascularisation reduce pain in chronic Achilles tendinopathy: a double blind randomised controlled trial. Knee Surg Sports Traumatol Arthrosc. 2005;13:338–44.CrossRefPubMedGoogle Scholar
  31. 31.
    Goldie I. Epicondylitis lateralis humeri (epicondylagia or tennis elbow). A pathogenetical study. Acta Chir Scand Suppl. 1964;57 suppl 339:1.PubMedGoogle Scholar
  32. 32.
    Coonrad RW, Hooper WR. Tennis elbow: its courses, natural history, conservative and surgical management. J Bone Joint Surg Am. 1973;55:1177–82.PubMedGoogle Scholar
  33. 33.
    Ahmad Z. Lateral epicondylitis. A review of pathology and management. Bone Joint J. 2013;95-B:1158–64.CrossRefPubMedGoogle Scholar
  34. 34.
    Chen J, Wang A, Xu J, et al. In chronic lateral epicondylitis, apoptosis and autophagic cell death occur in the extensor carpi radialis brevis tendon. J Shoulder Elbow Surg. 2010;19:355–62.CrossRefPubMedGoogle Scholar
  35. 35.
    Nirschl RP, Pettrone FA. Tennis elbow. The surgical treatment of lateral epicondylitis. J Bone Joint Surg Am. 1979;61(6A):832–9.PubMedGoogle Scholar
  36. 36.
    Brummel J, et al. Epicondylitis: lateral. Sports Med Arthrosc Rev. 2014;22:e1–6.CrossRefGoogle Scholar
  37. 37.
    Connell D, Burke F, Coombes P, et al. Sonographic examination of lateral epicondylitis. Am J Roentgenol. 2001;176:777–82.CrossRefGoogle Scholar
  38. 38.
    Van Hofwegen C, Baker 3rd CL, Baker Jr CL. Epicondylitis in the athlete’s elbow. Clin Sports Med. 2010;29:577–97.CrossRefPubMedGoogle Scholar
  39. 39.
    Buckup K. Clinical tests for the musculoskeletal system: examinations-sign-phenomena. 2nd ed. Stuttgart: Thieme; 2008. p. 129–33.Google Scholar
  40. 40.
    Gardner RC. Tennis elbow: diagnosis, pathology and treatment: nine severe cases treated by a new reconstructive operation. Clin Orthop. 1970;72:248–53.PubMedGoogle Scholar
  41. 41.
    Edelson G, Kunos CA, Vigder F, Obed E. Bony changes at the lateral epicondyle of possible significance in tennis elbow syndrome. J Shoulder Elbow Surg. 2001;10:158–63.CrossRefPubMedGoogle Scholar
  42. 42.
    Miller TT, Shapiro MA, Schultz E, et al. Comparison of sonography and MRI for diagnosing epicondylitis. J Clin Ultrasound. 2002;30:193–202.CrossRefPubMedGoogle Scholar
  43. 43.
    Naam NH, Nemani S. Radial tunnel syndrome. Orthop Clin North Am. 2012;43:529–36.CrossRefPubMedGoogle Scholar
  44. 44.
    Rajeev A, Pooley J. Lateral compartment cartilage changes and lateral elbow pain. Acta Orthop Belg. 2009;75:37–40.PubMedGoogle Scholar
  45. 45.
    Smidt N, Lewis M, van der Windt DAWM, Hay EM, Bouter LM, Croft P. Lateral epicondylitis in general practice: course and prognostic indicators of outcome. J Rheumatol. 2006;33:2053–9.PubMedGoogle Scholar
  46. 46.
    Sayegh ET, Strauch RJ. Does nonsurgical treatment improve longitudinal outcomes of lateral epicondylitis over no treatment? A meta-analysis. Clin Orthop Relat Res. 2015;473:1093–107.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Bisset L, et al. Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial. BMJ. 2006. doi: 10.1136/bmj.38961.584653.AE.Google Scholar
  48. 48.
    Coombes BK, et al. Effect of corticosteroid injection, physiotherapy, or both on clinical outcomes in patients with unilateral lateral epicondylalgia a randomized controlled trial. JAMA. 2013;309(5):461–9.CrossRefPubMedGoogle Scholar
  49. 49.
    Mardani-Kivi M, Karimi-Mobarakeh M, Karimi A, et al. The effects of corticosteroid injection versus local anesthetic injection in the treatment of lateral epicondylitis: a randomized single-blinded clinical trial. Arch Orthop Trauma Surg. 2013;133:757–63.CrossRefPubMedGoogle Scholar
  50. 50.
    Buchbinder R, Johnston RV, Barnsley L, Assendelft WJ, Bell SN, Smidt N. Surgery for lateral elbow pain. Cochrane Database Syst Rev. 2011;3:CD003525.PubMedGoogle Scholar
  51. 51.
    Hall MP, Band PA, Meislin RJ, Jazrawi LM, Cardone DA. Platelet-rich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg. 2009;17(10):602–8.PubMedGoogle Scholar
  52. 52.
    Sánchez M, Azofra J, Anitua E, et al. Plasma rich in growth factors to treat an articular cartilage avulsion: a case report. Med Sci Sports Exerc. 2003;35:1648–52.CrossRefPubMedGoogle Scholar
  53. 53.
    Sánchez M, Anitua E, Orive G, et al. Platelet-rich therapies in the treatment of orthopaedic sport injuries. Sports Med. 2009;39:345–54.CrossRefPubMedGoogle Scholar
  54. 54.
    Mishra A, Harmon K, Woodall Jr J, Vieira A. Sports medicine applications of platelet rich plasma. Curr Pharm Biotechnol. 2012;13(7):1185–95.CrossRefPubMedGoogle Scholar
  55. 55.
    Hsu WK, Mishra A, Rodeo SR, et al. Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment. J Am Acad Orthop Surg. 2013;21(12):739–48.CrossRefPubMedGoogle Scholar
  56. 56.
    Sánchez M, Albillos J, Angulo F, et al. Platelet-rich plasma in muscle and tendon healing. Oper Technol Orthop. 2012;22:16–24.CrossRefGoogle Scholar
  57. 57.
    Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27:158–67.CrossRefPubMedGoogle Scholar
  58. 58.
    DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system. Arthroscopy. 2012;28(7):998–1009.CrossRefPubMedGoogle Scholar
  59. 59.
    Mastrangelo AN, Vavken P, Fleming BC, et al. Reduced platelet concentration does not harm PRP effectiveness for ACL repair in a porcine in vivo model. J Orthop Res. 2011;29:1002–7.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Wiegerinck JI, Reilingh ML, de Jonge MC, et al. Injection techniques of platelet-rich plasma into and around the Achilles tendon: a cadaveric study. Am J Sports Med. 2011;39:1681–168.CrossRefPubMedGoogle Scholar
  61. 61.
    Dragoo JL, Braun HJ, Durham JL, et al. Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons. Am J Sports Med. 2012;40:1274–81.CrossRefPubMedGoogle Scholar
  62. 62.
    Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med. 2011;39:2135–40.CrossRefPubMedGoogle Scholar
  63. 63.
    Filardo G, Kon E, Pereira Ruiz MT, Vaccaro F, Guitaldi R, Di Martino A, Cenacchi A, Fornasari PM, Marcacci M. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc. 2012;20:2082–91.CrossRefPubMedGoogle Scholar
  64. 64.
    Carofino B, et al. Corticosteroids and local anesthetics decrease positive effects of platelet-rich plasma: an in vitro study on human tendon cells. Arthroscopy. 2012;28(5):711–9.CrossRefPubMedGoogle Scholar
  65. 65.
    Martin JI, et al. Platelet-rich plasma (PRP) in chronic epicondylitis: study protocol for a randomized controlled trial. Trials. 2013;14:410.CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Anitua E, Alkhraisat MH, Orive G. Perspectives and challenges in regenerative medicine using plasma rich in growth factors. J Control Release. 2012;157:29–38.CrossRefPubMedGoogle Scholar
  67. 67.
    Anitua E, Sanchez M, Orive G. Potential of endogenous regenerative technology for in situ regenerative medicine. Adv Drug Deliv Rev. 2010;62(7–8):741–52.CrossRefPubMedGoogle Scholar
  68. 68.
    Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost. 2011;105(Suppl1):S13–33.CrossRefPubMedGoogle Scholar
  69. 69.
    Discher DE, Mooney DJ, Zandstra PW. Growth factors, matrices, and forces combine and control stem cells. Science. 2009;324(5935):1673–7.CrossRefPubMedPubMedCentralGoogle Scholar
  70. 70.
    Martino MM, Briquez PS, Ranga A, et al. Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proc Natl Acad Sci U S A. 2013;110(12):4563–8.CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    Anitua E, Zalduendo M, Prado R, et al. Morphogen and pro‐inflammatory cytokine release kinetics from PRGF‐Endoret fibrin scaffolds: evaluation of the effect of leukocyte inclusion. J Biomed Mater Res A. 2015;103(3):1011–20.CrossRefPubMedGoogle Scholar
  72. 72.
    Anitua E, Orive G. Endogenous regenerative technology using plasma- and platelet-derived growth factors. J Control Release. 2012;157(3):317–20.CrossRefPubMedGoogle Scholar
  73. 73.
    Zhang J, Wang JHC. Platelet–rich plasma releasate promotes differentiation of tendon stem cells into active tenocytes. Am J Sports Med. 2010;38:2477–86.CrossRefPubMedGoogle Scholar
  74. 74.
    Schnabel LV, Mohammed HO, Miller BJ, et al. Platelet rich plasma (PRP) enhances the anabolic gene expression pattern in flexor digitorum superficialis tendons. J Orthop Res. 2007;25:230–40.CrossRefPubMedGoogle Scholar
  75. 75.
    Anitua E, Sanchez M, Zalduendo MM, et al. Fibroblastic response to treatment with different preparations rich in growth factors. Cell Prolif. 2009;41:162–70.CrossRefGoogle Scholar
  76. 76.
    Anitua E, Sanchez M, De la Fuente M, et al. Plasma rich in growth factors (PRGF-Endoret) stimulates tendon and synovial fibroblasts migration and improves the biological properties of hyaluronic acid. Knee Surg Sports Traumatol Arthrosc. 2012;20:1657–65.CrossRefPubMedGoogle Scholar
  77. 77.
    Anitua E, Sánchez M, Nurden AT, et al. Autologous fibrin matrices: a potential source of biological mediators that modulate tendon cell activities. J Biomed Mater Res. 2006;77:285–93.CrossRefGoogle Scholar
  78. 78.
    Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet rich plasma. Am J Sports Med. 2006;34:1774–8.CrossRefPubMedGoogle Scholar
  79. 79.
    Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: Platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med. 2010;38:255–62.CrossRefPubMedGoogle Scholar
  80. 80.
    Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double- blind randomized controlled trial with 2-year follow-up. Am J Sports Med. 2011;39:1200–8.CrossRefPubMedGoogle Scholar
  81. 81.
    Creaney L, Walla A, Curtis M, Connell D. Growth factor- based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, double-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections. Br J Sports Med. 2011;45:966–71.CrossRefPubMedGoogle Scholar
  82. 82.
    Thanasas C, Papadimitriou G, Charalambidis C, Paraskevopoulos I, Papanikolaou A. Platelet- rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. Am J Sports Med. 2011;39:2130–4.CrossRefPubMedGoogle Scholar
  83. 83.
    Omar Aziza S, Maha EI, Amal SA, Mahmoud S. Local injection of autologous platelet rich plasma and corticosteroid in treatment of lateral epicondylitis and plantar fasciitis: randomized clinical trial. Egypt Rheumatol. 2012;34:43–9.CrossRefGoogle Scholar
  84. 84.
    Krogh TP, Fredberg U, Stengaard-Pedersen K, et al. Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: a randomized, double-blind, placebo-controlled trial. Am J Sports Med. 2013;41:625–35.CrossRefPubMedGoogle Scholar
  85. 85.
    Mishra AK, Skrepnik NV, Edwards SG, et al. Efficacy of platelet-rich plasma for chronic tennis elbow: a double- blind, prospective, multicenter, randomized controlled trial of 230 patients. Am J Sports Med. 2014;42:463–71.CrossRefPubMedGoogle Scholar
  86. 86.
    Raeissadat SA, Rayegani SM, Hassanabadi H, et al. Is platelet-rich plasma superior to whole blood in the management of chronic tennis elbow: one year randomized clinical trial. BMC Sports Sci Med Rehabil. 2014;6:12.CrossRefPubMedPubMedCentralGoogle Scholar
  87. 87.
    Chaudhury S, de La Lama M, Adler RS, et al. Platelet-rich plasma for the treatment of lateral epicondylitis: sonographic assessment of tendon morphology and vascularity (pilot study). Skeletal Radiol. 2013;42:91–7.CrossRefPubMedGoogle Scholar
  88. 88.
    Hechtman KS, Uribe JW, Botto-vanDemden A, Kiebzak GM. Platelet-rich plasma injection reduces pain in patients with recalcitrant epicondylitis. Orthopedics. 2011;34:92.PubMedGoogle Scholar

Copyright information

© ESSKA 2016

Authors and Affiliations

  • Jorge Guadilla
    • 1
  • Emilio Lopez-Vidriero
    • 2
  • Rosa Lopez-Vidriero
    • 3
  • Sabino Padilla
    • 1
  • Diego Delgado
    • 1
  • Rafael Arriaza
    • 4
  • Mikel Sanchez
    • 1
  1. 1.Unidad de Cirugia ArtroscopicaVItoriaSpain
  2. 2.Traumatology, Department at Ibermutuamur SevillaISMEC. International Sports Medicine ClinicSevillaSpain
  3. 3.ISMEC. International Sports Medicine ClinicSevillaSpain
  4. 4.Arriaza AsociadosLa CoruñaSpain

Personalised recommendations